 The article discusses the development and evaluation of H7N9 influenza vaccine candidates in preclinical and clinical trials as well as ongoing clinical trials with H7N9 vaccines. It highlights the importance of influenza vaccines in protecting against influenza infections and notes that a large number of promising H7N9 vaccine candidates have been generated using traditional and advanced gene engineering techniques. Additionally, the article mentions the establishment of influenza vaccine production capacities in low and middle-income countries with high population density through whose GAP program, which allows these countries to be independent of vaccine supply from high-income countries. Overall, the article suggests that the world is now well prepared for a possible H7N9 influenza pandemic. This article was authored by Irina Isakova-Sivak and Larissa Rodenko.